KENDALL GJETAJ: Open Payments
NPI 1336669993 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 71 payments from 21 companies in 2025. Trend: 2023 $1,707 · 2024 $1,763 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $248 |
| ABBVIE INC. | 14 | $211 |
| PFIZER INC. | 9 | $157 |
| Exact Sciences Corporation | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Astellas Pharma US Inc | 3 | $64 |
| Viatris Specialty LLC | 3 | $63 |
| SHIELD THERAPEUTICS INC | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: Wegovy, PREVNAR 20, Cologuard Collection Kit, UBRELVY, GVOKE HYPOPEN, CREON, Rybelsus, Veozah.
Industry payments across MI — which companies pay providers there.
